Drug Target Review
JANUARY 14, 2025
In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. Nina Truter Nina Truter is a translational scientist with a deep focus on understanding mechanisms of action in drug development and leveraging disparate datasets in biotech.
Drug Target Review
DECEMBER 6, 2024
In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry. For more: [link] ; [link] ; [link] ; [link] Nina Truter Nina Truter is a translational scientist with a deep focus on understanding mechanisms of action in drug development and leveraging disparate datasets in biotech.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Target Review
OCTOBER 14, 2024
Wilkie’s background as a biochemist and his time at Merck, a leading pharmaceutical company, shaped his early understanding of drug development and business strategy. As someone who describes himself as an “enthusiastic sceptic,” Wilkie is cautious but hopeful about the potential of AI in drug development. “I
Drug Target Review
DECEMBER 14, 2023
She continued: “Now that we know more about this pathway, scientists could, in theory, produce a drug that could disrupt key pieces of the pathway in cancer cells, as opposed to using conventional chemotherapies that destroy healthy cells along with the cancer.” Polymerase theta TMEJ has been the most elusive DNA repair pathway.
Perficient: Drug Development
FEBRUARY 22, 2024
I worked on many projects with them in my early career (2003-2013). A Real-World Personal Example – Zagging to Success A successful “zag” with a great idea doesn’t need to be risky. Atlas Van Lines is in the moving and relocation industry. We did amazing work together.
The Premier Consulting Blog
AUGUST 21, 2024
Similarly, clinical submissions to the Central Drugs Standard Control Organisation (CDSCDO) in India accept the EU Q-IMPD format. The Dossier de Desenvolvimento Clínico de Medicamento (DDCM), translated Clinical Drug Development Dossier, is submitted to the Brazilian regulatory authority Agência Nacional de Vigilância Sanitária (ANVISA).
Perficient: Drug Development
OCTOBER 3, 2023
Bill has led marketing at Perficient since 2003, in a period of intense growth. Bill Davis Senior Vice President, Marketing & Alliances As senior vice president of marketing and alliances, Bill Davis is responsible for Perficient’s global marketing and communications functions.
Expert insights. Personalized for you.
69 
Let's personalize your content